Document is current

Any future updates will be listed below

Novel Liposomal Nanocarrier of Dasatinib for Enhanced Chronic Myeloid Leukemia Treatment: Improved Pharmacokinetics and Reduced Toxicity

Crossref DOI link: https://doi.org/10.1007/s12247-025-10204-3

Published Online: 2025-10-22

Published Print: 2025-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark